
Novartis
2025年3月19日 · Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Investors - Novartis
2025年1月31日 · Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information. Discover how Novartis turns breakthrough science into transformative, high-value treatments.
Novartis AG | Swiss Pharmaceutical Giant | Britannica Money
2025年3月20日 · Novartis AG, Swiss company that is one of the world’s largest manufacturers of pharmaceuticals. It was formed in 1997 from the merger of two major Swiss drug companies, Ciba-Geigy AG and Sandoz AG. Novartis is headquartered in Basel. Ciba-Geigy originated in the merger of two smaller Swiss firms, Ciba AG and J.R. Geigy SA.
Novartis Holds a Strong Branded Drug Portfolio Supporting
1 天前 · Novartis primarily uses its cash to fund its dividend, which represents close to 50% of the company's core earnings. We expect continued dividend increases but a slow rate over the next few years.
Novartis AG, NOVN:SWX profile - FT.com - Financial Times
5 天之前 · Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs),...
Novartis receives third FDA approval for oral Fabhalta®
2025年3月20日 · Novartis Media Relations E-mail: [email protected] Novartis Investor Relations Central investor relations line: +41 61 324 7944 E-mail: [email protected]
Novartis AG Company Profile | Basel, BASEL-STADT, Switzerland ...
Find company research, competitor information, contact details & financial data for Novartis AG of Basel, BASEL-STADT. Get the latest business insights from Dun & Bradstreet.
About - Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach …
Novartis AG (NVS) Company Profile & Description - Stock Analysis
1991年11月18日 · Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
Novartis United States of America
2025年3月20日 · Every day, we work to reimagine medicine to improve and extend people’s lives. Learn about us and our story. Visit resources tailored for our patient communities and their caregivers, including information around patient assistance, …
- 某些结果已被删除一些您可能无法访问的结果已被隐去。显示无法访问的结果